TPTX - Turning Point Therapeutics Inc. (TPTX) CEO Athena Countouriotis on Q3 2019 Results - Earnings Call Transcript
Turning Point Therapeutics, Inc. (TPTX)
Q3 2019 Earnings Conference Call
November 4, 2019 04:30 PM ET
Company Participants
Jim Mazzola - Senior Vice President, Communication and Investor Relations
Athena Countouriotis - President and Chief Executive Officer
Yi Larson - Executive Vice President and Chief Financial Officer
Conference Call Participants
Michael Schmidt - Guggenheim Securities
Paul Choi - Goldman Sachs
Andrew Berens - SVB Leerink
Arlinda Lee - Canaccord Genuity
Yanan Zhu - Wells Fargo Securities LLC
Presentation
Operator
Good afternoon, ladies and gentlemen, and welcome to the Turning Point Therapeutics' Third Quarter 2019 Conference Call.